X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (17) 17
female (11) 11
male (10) 10
pharmacokinetics (10) 10
adult (9) 9
child (9) 9
young adult (9) 9
infant (8) 8
adolescent (7) 7
child, preschool (7) 7
transplantation (7) 7
article (6) 6
busulfan (6) 6
hematopoietic stem cell transplantation (6) 6
hematopoietic stem cells (6) 6
analysis (5) 5
pediatric (5) 5
pediatric-patients (5) 5
pediatrics (5) 5
pharmacology & pharmacy (5) 5
abridged index medicus (4) 4
health aspects (4) 4
hematology (4) 4
hematology, oncology and palliative medicine (4) 4
hematopoietic cell transplantation (4) 4
immunology (4) 4
immunosuppressive agents - pharmacokinetics (4) 4
infant, newborn (4) 4
middle aged (4) 4
models, biological (4) 4
retrospective studies (4) 4
treatment outcome (4) 4
area under curve (3) 3
bone-marrow-transplantation (3) 3
busulfan - pharmacokinetics (3) 3
busulfan - therapeutic use (3) 3
dosage and administration (3) 3
hematopoietic stem cell transplantation - mortality (3) 3
immunosuppressive agents - administration & dosage (3) 3
leukemia (3) 3
pharmacogenetics (3) 3
pharmacology (3) 3
pharmacy (3) 3
recipients (3) 3
research (3) 3
severe combined immunodeficiency (3) 3
stem cells (3) 3
stem-cell transplantation (3) 3
transplantation conditioning (3) 3
transplantation conditioning - methods (3) 3
transplants & implants (3) 3
vidarabine - analogs & derivatives (3) 3
age factors (2) 2
aged (2) 2
biology (2) 2
body weight (2) 2
busulfan - administration & dosage (2) 2
care and treatment (2) 2
children (2) 2
cohort studies (2) 2
cord blood transplantation (2) 2
disease (2) 2
disposition (2) 2
dose-response relationship, drug (2) 2
double-blind method (2) 2
drug monitoring (2) 2
drugstores (2) 2
gene (2) 2
gene therapy (2) 2
graft survival - drug effects (2) 2
graft vs host disease - epidemiology (2) 2
hematopoietic stem cell transplantation - adverse effects (2) 2
hemopoiesis (2) 2
hepatic venoocclusive disease (2) 2
hypertension, pulmonary - drug therapy (2) 2
ii trial (2) 2
immunosuppressive agents - adverse effects (2) 2
infants (2) 2
internal medicine (2) 2
intravenous administration (2) 2
intravenous busulfan (2) 2
long-term survival (2) 2
marrow transplantation (2) 2
medical laboratory technology (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
metabolic clearance rate (2) 2
methods (2) 2
morphogenetic protein-receptor (2) 2
mortality (2) 2
mutations (2) 2
mycophenolic acid - pharmacokinetics (2) 2
oncology (2) 2
organ transplant recipients (2) 2
outcomes (2) 2
pharmacology/toxicology (2) 2
phase-i (2) 2
plasma (2) 2
precision medicine (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1155 - 1155
Abstract Background: Allogeneic hematopoietic cell transplantation (aHCT) is curative for a number of pediatric nonmalignant disorders. Toxicities related to... 
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 133, Issue 2, pp. 335 - 347.e11
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2019, Volume 380, Issue 16, pp. 1525 - 1534
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 2014, Volume 36, Issue 2, pp. 169 - 174
Journal Article
International Journal of Pediatric Otorhinolaryngology, ISSN 0165-5876, 02/2018, Volume 105, pp. 48 - 51
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 11, pp. e526 - e536
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2012, Volume 18, Issue 11, pp. 1656 - 1663
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 01/2011, Volume 46, Issue 1, pp. 20 - 26
Despite its common use in nonmyeloablative preparative regimens, the pharmacokinetics of fludarabine are poorly characterized in hematopoietic cell... 
fludarabine | pharmacokinetics | nonmyeloablative | TRM | F-ara-A | RELAPSED LEUKEMIA | 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE 5'-MONOPHOSPHATE | II TRIAL | IMMUNOLOGY | TRANSPLANTATION | CORD BLOOD TRANSPLANTATION | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | DEOXYCYTIDINE KINASE | ONCOLOGY | PEDIATRIC-PATIENTS | CHRONIC LYMPHOCYTIC-LEUKEMIA | HEMATOLOGY | HEMATOLOGIC MALIGNANCIES | Graft vs Host Disease - epidemiology | Humans | Immunosuppressive Agents - pharmacokinetics | Middle Aged | Vidarabine - blood | Male | Metabolic Clearance Rate | Hematopoietic Stem Cell Transplantation - mortality | Incidence | Young Adult | Immunosuppressive Agents - blood | Vidarabine Phosphate - analogs & derivatives | Vidarabine Phosphate - adverse effects | Adult | Female | Renal Insufficiency - complications | Vidarabine Phosphate - therapeutic use | Immunosuppressive Agents - administration & dosage | Neutrophil Infiltration - drug effects | Risk Factors | Renal Insufficiency - metabolism | Vidarabine - analogs & derivatives | Prodrugs - adverse effects | Vidarabine Phosphate - pharmacokinetics | Prodrugs - pharmacokinetics | Survival Analysis | Immunosuppressive Agents - adverse effects | Aged | Prodrugs - therapeutic use | Transplantation Conditioning | Drug Monitoring | Graft Survival - drug effects | Complications and side effects | Care and treatment | Fludarabine | Patient outcomes | Dosage and administration | Transplantation | Hematopoietic stem cells | Cancer | Graft-versus-host reaction | Renal insufficiency | Toxicity | Mortality | Bone marrow transplantation | Data processing | Dose-response effects | Pharmacokinetics | Hemopoiesis | treatment related mortality | f-ara-a
Journal Article
Journal Article
PLoS biology, ISSN 1545-7885, 01/2019, Volume 17, Issue 1, p. e3000119
[This corrects the article DOI: 10.1371/journal.pbio.2005924.]. 
Journal Article